Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2081studies shown
Showing 541-552 of 2,081
Other study type icon
RecruitingISRCTN25898179

Rehabilitation Effectiveness for Activities for Life

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.

In United Kingdom
SchizophreniaOther
Countries
United Kingdom
Sponsor
University College London (UK)
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN69299093

Relatives Education And Coping Toolkit (REACT)

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.

In United Kingdom
SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Lancashire Care NHS Trust (UK)
Condition
Schizophrenia
Other study type icon
RecruitingNCT07003529

Role of Inferior Colliculi in Auditory Hallucinations

This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.

In Nîmes
SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
Schizophrenia
Other study type icon
RecruitingNCT05851950

RUFUS - Group Rumination-focused CBT for Negative Symptoms

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Denmark.

In Copenhagen
SchizophreniaOtherFrom 18 Years to 37 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Schizophrenia
Other study type icon
RecruitingNCT06640803

Sacramento Clinical High Risk for Psychosis Stepped-Care Program

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

Multiple locations, including Elk Grove
SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Schizophrenia
Other study type icon
RecruitingNCT05184335

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

Multiple locations, including Phoenix
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Reviva Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.